EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RNase footprinting demonstrates antigenomic hepatitis delta virus ribozyme structural rearrangement as a result of self-cleavage reaction


Bmc Research Notes 1(): 15-15
RNase footprinting demonstrates antigenomic hepatitis delta virus ribozyme structural rearrangement as a result of self-cleavage reaction
Hepatitis delta virus (HDV) is a satellite virus of hepatitis B. During viral replication the 1700-nucleotide-long genomic RNA and its complement, the antigenomic RNA, undergo self-cleavage catalyzed by internal ribozyme motifs that are essential for propagation of the virus in vivo. These self-cleavage activities are provided by 85-nucleotide-long sequence elements, the genomic and antigenomic forms of HDV ribozyme. Recently four permuted variants of the antigenomic HDV cis-ribozyme with a self-cleavage site located at the 5' proximity, in the middle, or nearby the 3' end of the molecule were constructed and synthesized. These constructs exhibit equal activity, a bi-phasic kinetics of self-cleavage reaction and reaction products with low and high stability. We have used ribonuclease probing to footprint the structures of uncleaved and post-cleaved forms of the antigenomic HDV ribozymes in solution. Uncleaved ribozymes, associated and individual products of the self-cleavage reaction were analyzed using ribonuclease and Fe(II)-EDTA protection assays to reveal the differences in the structure of pre- and post-cleaved antigenomic HDV ribozyme in solution. Our findings demonstrate that a significant conformational change accompanies catalysis in the antigenomic HDV ribozyme in solution, in contrast to minor conformational switch observed in crystals of the genomic form. This study indicates that changes in the structure of stem P1 and stem P4 are minor, those of the region ascribed to stem P2, stem P3 and loop l3 are dramatic, while stem P1.1 results from the self-cleavage reaction. Our data agree with the structure of post-cleaved and disagree with that of pre-cleaved forms of HDV ribozyme published elsewhere.


Accession: 055338016

PMID: 18710542

DOI: 10.1186/1756-0500-1-15



Related references

A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme. Nucleic Acids Research 35(20): 6820-6831, 2007

Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme. Journal of Molecular Biology 341(2): 389-403, 2004

Effects of circular permutation on the cis-cleavage reaction of a hepatitis delta virus ribozyme: application to trans-acting ribozyme design. Biochemistry 35(1): 124-131, 1996

Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme. Nucleic Acids Research 31(8): 2087-2096, 2003

Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs. Nucleosides, Nucleotides & Nucleic Acids 23(6-7): 935-942, 2004

Ribozyme activity in the genomic and antigenomic RNA strands of hepatitis delta virus. CMLS Cellular & Molecular Life Sciences 59(1): 112-125, January, 2002

Ribozyme activity in the genomic and antigenomic RNA strands of hepatitis delta virus. Cellular and Molecular Life Sciences 59(1): 112-125, 2002

Properties of antigenomic hepatitis delta virus ribozyme that consists of three RNA oligomer strands. Biochemistry. Biokhimiia 68(11): 1231-1238, 2003

Deriving a 67-nucleotide trans-cleaving ribozyme from the hepatitis delta virus antigenomic RNA. Antisense Research and Development 2(4): 267-277, 1992

Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. Journal of Molecular Biology 259(5): 916-925, 1996